Medicus Pharma Ltd (NASDAQ:MDCX) | WebDisclosure

Basculer en Français

10051	Companies
205007	Keywords
135239	Articles
108683	Press releases

Home
Companies
Medicus Pharma Ltd

PRESS RELEASE

published on 10/22/2025 at 13:30, 4 months 27 days ago

Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Medicus Pharma enrolls first patient in SKNJCT-004 phase 2 clinical study for non-invasive BCC treatment in UAE with Cleveland Clinic Abu Dhabi as lead investigator

Clinical Study Medicus Pharma SKNJCT-004 BCC Treatment Cleveland Clinic Abu Dhabi
BRIEF

published on 10/13/2025 at 13:35, 5 months 5 days ago

Medicus Pharma Ltd. présentera au Maxim Growth Summit 2025

Conférence Sur Les Biotechnologies Medicus Pharma Teverelix Sommet Maxim Growth Injection Cutanée
BRIEF

published on 10/13/2025 at 13:35, 5 months 5 days ago

Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025

Biotech Conference Medicus Pharma Teverelix Maxim Growth Summit Skinject
PRESS RELEASE

published on 10/13/2025 at 13:30, 5 months 5 days ago

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer)

Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRIEF

published on 10/07/2025 at 13:35, 5 months 11 days ago

Medicus Pharma participera au sommet des family offices de Dubaï

Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRIEF

published on 10/07/2025 at 13:35, 5 months 11 days ago

Medicus Pharma to Participate in Dubai Family Office Summit

Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
PRESS RELEASE

published on 10/07/2025 at 13:30, 5 months 11 days ago

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai

Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRIEF

published on 09/29/2025 at 13:35, 5 months 19 days ago

Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject

Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
BRIEF

published on 09/29/2025 at 13:35, 5 months 19 days ago

Medicus Pharma Ltd. Gains FDA Support for Skinject Development

FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
PRESS RELEASE

published on 09/29/2025 at 13:30, 5 months 19 days ago

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026

FDA Clinical Study Medicus Pharma Skinject D-MNA BCC

Accesswire

Published on 03/18/2026 at 14:30, 11 minutes ago

Ground Geophysics Underway at Murphy Lake, 5 km From Isoenergy's Hurricane Deposit, Athabasca Basin
Published on 03/18/2026 at 14:15, 26 minutes ago

Apex Provides Phase I Drilling Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 03/18/2026 at 14:00, 41 minutes ago

Route1 Announces Filing of Parking Copilot Patent Application and Confirms Expected Launch Date for "Mr. Parking"
Published on 03/18/2026 at 14:00, 41 minutes ago

FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
Published on 03/18/2026 at 13:30, 1 hour 11 minutes ago

Predictiv AI Launches AGORACOM Marketing Program and Engages Venture Liquidity Partners for Market Making

View all ACCESSWIRE

EQS Group

Published on 03/18/2026 at 14:25, 15 minutes ago

Ethisphere recognizes Infosys among 2026 World's Most Ethical Companies®
Published on 03/18/2026 at 14:25, 15 minutes ago

PSI postpones the release of its 2025 annual and consolidated financial statements until the end of April 2026
Published on 03/18/2026 at 14:20, 20 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 03/18/2026 at 14:19, 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/18/2026 at 14:18, 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 03/18/2026 at 07:00, 7 hours 41 minutes ago

Mersen: A resilient performance in 2025, return to growth expected in 2026
Published on 03/18/2026 at 07:00, 7 hours 41 minutes ago

Mersen : Performance résiliente en 2025, retour attendu de la croissance en 2026
Published on 03/17/2026 at 23:43, 14 hours 57 minutes ago

SUEZ finalise la cession de c. 4% des titres ACEA
Published on 03/17/2026 at 17:45, 20 hours 55 minutes ago

SUEZ International SAS lance la cession de titres ACEA
Published on 03/17/2026 at 10:21, 1 day 4 hours ago

Communiqué de mise à disposition du Document d'enregistrement universel 2025 incluant le Rapport Financier Annuel

View all LES ECHOS COMFI WIRE